Likewise, Todaro et al. (2013) have demonstrated that breast cancer stem-like cells isolated from tumor tissues express the EPOR and respond to EPO treatment with increased proliferation and resistance to chemotherapeutic agents. Here, EPO is linked to neoplasm.